Publications for Måns Edström
Co-author map based on ISI articles 2007-

Publications mentioned in social media 11 times*

Journal Articles

Mika Gustafsson, Måns Edström, Danuta Gawel, Colm Nestor, Hui Wang, Huan Zhang, Fredrik Barrenäs, James Tojo, Ingrid Kockum, Tomas Olsson, Jordi Serra-Musach, Nuria Bonifaci, Miguel Angel Pujana, Jan Ernerudh and Mikael Benson
  Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment
Altmetric usage: 11

  Genome Medicine, 2014, 6(17), .
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Johan Mellergård, Måns Edström, Maria Jenmalm, Charlotte Dahle, Magnus Vrethem and Jan Ernerudh
  An Increase in B cell and Cytotoxic NK cell Proportions and Increased T cell Responsiveness in Blood of Natalizumab-treated Multiple Sclerosis Patients
  PLoS ONE, 2013, 8(12), e81685.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Måns Edström, Johan Mellergård, Jenny Mjösberg, Maria Jenmalm, Magnus Vrethem, R Press, Charlotte Dahle and Jan Ernerudh
  Transcriptional characteristics of CD4+ T cells in multiple sclerosis: relative lack of suppressive populations in blood
  Multiple Sclerosis, 2011, 17(1), 57-66.
 Web of Science® Times Cited: 11

Johan Mellergård, Måns Edström, Magnus Vrethem, Jan Ernerudh and Charlotte Dahle
  Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid
  Multiple Sclerosis, 2010, 16(2), 208-217.
   Fulltext  PDF  
 Web of Science® Times Cited: 52

Conference Articles

Måns Edström, Charlotte Dahle, Maria Jenmalm, Johan Mellergård, Jenny Mjösberg, Rayomand Press, Magnus Vrethem and Jan Ernerudh
  Th1/Th2/Th17 and Treg related transcription factors and cytokines in multiple sclerosis

Ph.D. Theses

Måns Edström
  Regulation of immunity in Multiple Sclerosis: CD4+ T cells and the influence of natalizumab

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by